Liz Dallimore – CEO & Managing Director – Argenica Therapeutics is developing novel neuroprotective therapeutics to reduce brain damage after stroke.
Post Views: 236
Liz Dallimore – CEO & Managing Director – Argenica Therapeutics is developing novel neuroprotective therapeutics to reduce brain damage after stroke.